APLT
Price:
$5.7
Market Cap:
$654.62M
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products in...[Read more]
Industry
Biotechnology
IPO Date
2019-05-14
Stock Exchange
NASDAQ
Ticker
APLT
According to Applied Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 532.64M. This represents a change of 32.22% compared to the average of 402.85M of the last 4 quarters.
The mean historical Enterprise Value of Applied Therapeutics, Inc. over the last ten years is 190.61M. The current 532.64M Enterprise Value has changed 27.84% with respect to the historical average. Over the past ten years (40 quarters), APLT's Enterprise Value was at its highest in in the June 2020 quarter at 701.77M. The Enterprise Value was at its lowest in in the June 2022 quarter at -29103406.37.
Average
190.61M
Median
176.55M
Minimum
12.98M
Maximum
427.75M
Discovering the peaks and valleys of Applied Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.70%
Maximum Annual Enterprise Value = 427.75M
Minimum Annual Increase = -92.65%
Minimum Annual Enterprise Value = 12.98M
Year | Enterprise Value | Change |
---|---|---|
2023 | 233.55M | 1.70% |
2022 | 12.98M | -92.65% |
2021 | 176.55M | -58.73% |
2020 | 427.75M | 28.37% |
2019 | 333.22M | 394.51% |
2018 | 67.39M | -18.67% |
The current Enterprise Value of Applied Therapeutics, Inc. (APLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
141.03M
5-year avg
236.81M
10-year avg
190.61M
Applied Therapeutics, Inc.’s Enterprise Value is greater than X4 Pharmaceuticals, Inc. (40.79M), greater than Galera Therapeutics, Inc. (-5475585.00), greater than Terns Pharmaceuticals, Inc. (458.36M), less than Day One Biopharmaceuticals, Inc. (1.01B), greater than HOOKIPA Pharma Inc. (87.25M), greater than Lyra Therapeutics, Inc. (22.69M), greater than Shattuck Labs, Inc. (110.17M), greater than Vincerx Pharma, Inc. (15.98M), greater than BioAtla, Inc. (24.10M), greater than Gain Therapeutics, Inc. (10.68M), greater than TFF Pharmaceuticals, Inc. (1.89M), greater than aTyr Pharma, Inc. (138.44M), greater than IN8bio, Inc. (9.90M), greater than Lantern Pharma Inc. (24.06M), greater than Anebulo Pharmaceuticals, Inc. (41.53M), greater than Acrivon Therapeutics, Inc. Common Stock (208.47M), greater than PMV Pharmaceuticals, Inc. (40.92M), greater than Molecular Partners AG (-1929773.37), greater than Mineralys Therapeutics, Inc. (490.57M), greater than Seer, Inc. (95.89M), less than ORIC Pharmaceuticals, Inc. (633.67M), less than Cullinan Oncology, Inc. (930.13M), greater than C4 Therapeutics, Inc. (369.73M),
Company | Enterprise Value | Market cap |
---|---|---|
40.79M | $109.78M | |
-5475585.00 | $4.08M | |
458.36M | $549.60M | |
1.01B | $1.25B | |
87.25M | $159.50M | |
22.69M | $17.85M | |
110.17M | $167.05M | |
15.98M | $22.05M | |
24.10M | $84.10M | |
10.68M | $26.81M | |
1.89M | $6.20M | |
138.44M | $131.12M | |
9.90M | $14.22M | |
24.06M | $36.82M | |
41.53M | $46.68M | |
208.47M | $250.26M | |
40.92M | $77.28M | |
-1929773.37 | $182.90M | |
490.57M | $558.43M | |
95.89M | $100.74M | |
633.67M | $680.74M | |
930.13M | $1.04B | |
369.73M | $374.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Applied Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Applied Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Applied Therapeutics, Inc. (APLT)?
What is the 3-year average Enterprise Value for Applied Therapeutics, Inc. (APLT)?
What is the 5-year average Enterprise Value for Applied Therapeutics, Inc. (APLT)?
How does the current Enterprise Value for Applied Therapeutics, Inc. (APLT) compare to its historical average?